Following U.S. Stocks may claim a “BIG Change,” in the course of current trading session: Cellular Dynamics International Inc (NASDAQ:ICEL)
Cellular Dynamics International Inc (NASDAQ:ICEL), with shares skyrocketed 107.84% is now trading at $16.50, hitting new 52-week high of $16.52. The Stock is active as 960,211.00 shares changed hands versus its average volume of 100,546.00 shares. For the last twelve months, the stock was able to keep return on equity at -65.40%, while return on assets at -46.10%, in response to its return on investment at -58.50%. Its 20-day moving average inclined 125.38%, above 50-day moving average of 169.45%, above 200-day moving average of 96.41% from the latest market price of $16.50. The mean recommendation of analysts for this stock is 1.70.(where 1=Buy, 5=Sale).
Latest NEWS regarding these Stocks are depicted underneath:
Cellular Dynamics International, Inc. (NASDAQ:ICEL)
Today, FUJIFILM Holdings Corporation and Cellular Dynamics International, Inc. (ICEL), declared that the two companies have reached a definitive contract whereby Fujifilm will attain CDI via an all-cash tender offer to be followed by a second step merger. Fujifilm aims to attain all issued and outstanding shares of CDI’s ordinary stock for $16.5 per share or about $ 307 million (on a fully diluted basis). The offer represents a premium of 108% to CDI’s closing price on March 27. Upon completion of the transaction, CDI will continue to run its operations in Madison, Wisconsin and Novato, California as a merged partner of Fujifilm. The declared transaction was unanimously approved by the Boards of Directors of both companies.
Under the terms of the contract, Fujifilm will commence an all-cash tender offer no later than April 6, 2015. The transaction is conditioned on the tender achieving the minimum acceptance threshold, regulatory approvals and other customary conditions. Fujifilm will finance the transaction from the cash on its balance sheet and the completion of the attainment is not subject to any financing conditions. It is anticipated that the tender offer will close during the second calendar quarter of 2015.
CDI was founded in 2004 and listed on NASDAQ in July 2013. The corporation had global proceeds of $16.7 million in the year ended, December 31, 2014 and had 155 employees as of December 31, 2014.
This attainment of CDI will allow Fujifilm to gain entry into the area of iPS cell-based drug discovery support services. Fujifilm also plans to benefit from the combination of CDI’s iPS cell technology and experience and Fujifilm’s expertise in material science, engineering, and J-TEC’s quality administration systems. The combination of these will assist accelerate product development in regenerative medicine while expanding the commercial opportunities.
Cellular Dynamics International, Inc. develops and manufactures human cells in the United States, Europe, Japan, and internationally. The corporation’s proprietary products comprise human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs), and custom iPSCs and iCell products (MyCell products).
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
